Loxo Oncology, Inc. 4 SEC Filings

Filed On	Filing
15 Feb 2019	Form 4: Van Naarden Jacob, Chief Operating Officer Returned 19,000 shares to the issuer ($4.47M) · Disposed of 522,969 Employee Stock Option (Right to Buy) (Disposition to Issuer) ($123M)
15 Feb 2019	Form 4: Nanda Nisha, Chief Development Officer Returned 18,896 shares to the issuer ($4.44M) · Disposed of 213,702 Employee Stock Option (Right to Buy) (Disposition to Issuer) ($50.2M)
15 Feb 2019	Form 4: Naider Avi Z., Director Gave 15,000 shares as a gift · Returned 111,843 shares to the issuer ($26.3M) · Disposed of 50,999 Employee Stock Option (Right to Buy) (Disposition to Issuer) ($12M)
15 Feb 2019	Form 4: Mayleben Timothy M, Director Disposed of 30,187 Employee Stock Option (Right to Buy) (Disposition to Issuer) ($7.09M)
15 Feb 2019	Form 4: Kunkel Lori Anne, Director Disposed of 104,592 Employee Stock Option (Right to Buy) (Disposition to Issuer) ($24.6M)
15 Feb 2019	Form 4: Harr Steve, Director Disposed of 35,375 Employee Stock Option (Right to Buy) (Disposition to Issuer) ($8.31M)
15 Feb 2019	Form 4: Fuhrman Alan, Director Disposed of 48,374 Employee Stock Option (Right to Buy) (Disposition to Issuer) ($11.4M)
15 Feb 2019	Form 4: Flaherty Keith T., Director Returned 9,732 shares to the issuer ($2.29M) · Disposed of 198,423 Employee Stock Option (Right to Buy) (Disposition to Issuer) ($46.6M)
15 Feb 2019	Form 4: Elms Steve, Director Disposed of 2,038,920 shares (Tender Offer) ($479M) · Disposed of 50,999 Employee Stock Option (Right to Buy) (Disposition to Issuer) ($12M)
15 Feb 2019	Form 4: Burstein Jennifer, Senior VP of Finance Disposed of 145,500 Employee Stock Option (Right to Buy) (Disposition to Issuer) ($34.2M)
15 Feb 2019	Form 4: Bilenker Joshua H., Director Returned 192,707 shares to the issuer ($45.3M) · Disposed of 1,289,444 Employee Stock Option (Right to Buy) (Disposition to Issuer) ($303M)
02 Jan 2019	Form 4: Nanda Nisha, Chief Development Officer Granted 37,000 Employee Stock Option (Right to Buy)
02 Jan 2019	Form 4: Burstein Jennifer, Senior VP of Finance Granted 20,000 Employee Stock Option (Right to Buy)
02 Jan 2019	Form 4: Van Naarden Jacob, Chief Operating Officer Granted 57,000 Employee Stock Option (Right to Buy)
02 Jan 2019	Form 4: Bilenker Joshua H., Director Granted 128,000 Employee Stock Option (Right to Buy)
17 Dec 2018	Form 4: Naider Avi Z., Director Bought 725 shares ($101K)
12 Dec 2018	Form 4: Van Naarden Jacob, Chief Business Officer Received 4,500 shares by exercise or conversion ($61.5K) · Sold 4,500 shares ($601K) · Received 11,500 shares by exercise or conversion ($87.1K) · 1 more
12 Dec 2018	Form 4: Burstein Jennifer, Senior VP of Finance Received 1,250 shares by exercise or conversion ($14.2K) · Sold 1,250 shares ($167K) · Received 1,250 shares by exercise or conversion ($14.2K) · 1 more
12 Dec 2018	Form 4: Bilenker Joshua H., Director Received 10,000 shares by exercise or conversion ($137K) · Sold 10,000 shares ($1.34M) · Received 10,000 shares by exercise or conversion ($137K) · 1 more
28 Nov 2018	Form 4: Van Naarden Jacob, Chief Business Officer Received 5,500 shares by exercise or conversion ($20.1K) · Sold 5,500 shares ($842K) · Received 4,500 shares by exercise or conversion ($37K) · 1 more

Comments